Showing results (11-20 of 224) with videos related to

Sort By:
Pageof 23
Expert Opinion on Emerging Drugs|March 8, 2019
Emerging drugs for treating the acute respiratory distress syndromeTimothy D Shaw, Daniel F McAuley, Cecilia M O'Kane
Critical Care (London, England)|September 1, 2010
Assessing the quantity of pulmonary edema in critically ill childrenDaniel F McAuley, Lisa M Brown, Michael A Matthay
Critical Care Medicine|December 18, 2010
A stepwise approach to justify phase III randomized clinical trials and enhance the likelihood of a positive resultDaniel F McAuley, Cecilia O'kane, Mark J D Griffiths
Lancet (London, England)|September 7, 2022
Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and managementEllen A Gorman, Cecilia M O'Kane, Daniel F McAuley
The Lancet. Respiratory Medicine|July 1, 2017
Clinical trials in acute respiratory distress syndrome: challenges and opportunitiesMichael A Matthay, Daniel F McAuley, Lorraine B Ware
Critical Care Explorations|December 2, 2025
The POETIC (PrOcess Evaluation of Trials In Critical care) Framework: A Structured Approach for Designing and Conducting Process Evaluations in Critical Care TrialsLydia M Emerson, Daniel F McAuley, Bronagh Blackwood, et al.
Respiratory Research|August 28, 2010
Helium-oxygen reduces the production of carbon dioxide during weaning from mechanical ventilationGordon Flynn, Gerlinde Mandersloot, Marie Healy, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|March 28, 2018
Designing a nurse-delivered delirium bundle: What intensive care unit staff, survivors, and their families think?Leona Bannon, Jennifer McGaughey, Mike Clarke, et al.
Critical Care Medicine|July 9, 2004
Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injuryDaniel F McAuley, James A Frank, Xiaohui Fang, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2005
The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trialGavin D Perkins, Daniel F McAuley, David R Thickett, et al.
Pageof 23